CooperSurgical, Inc.
Form 483 issued July 15, 2021 · Trumbull, Connecticut
- Inspection
- Jul 7 – Jul 15, 2021
- Investigator
- Stephen C. Smith
- Observations
- 4
- Pages
- 7
- FEI number
- 1216677
In short: On July 15, 2021, FDA issued a Form 483 with 4 observations to CooperSurgical, Inc. in Trumbull, Connecticut (FEI 1216677) after an inspection that ran Jul 7 – Jul 15, 2021. The investigator was Stephen C. Smith. Most observations concern production & process controls and cAPA.
At a glance
Production & process controls and capa account for 4 of 4 observations.
What FDA observed
Preview: the opening words of each observation- 01
Labeling and packaging operations were not controlled…
- 02
An MDR report was not submitted within 30 days of receiving or otherwise becoming aware of…
- 03
Procedures that define the responsibility for review and the authority for the disposition of nonconforming product…
- 04
Procedures to control environmental conditions have…
This inspection in context
Stephen C. Smith
4 documents · 2015–2021
Cites 803.30 (if i am a user facility, what reporting requirements apply to me?) more than any other section. Most of their documents are for sites in New Hampshire.
The firmCooperSurgical, Inc. history
All 3 documents on file for this site, in date order, with what was cited at each inspection.
Similar 483sOther sites cited under 820.120(d)
See how FDA wrote the same problem up elsewhere.
Questions about this 483
What did FDA find at CooperSurgical, Inc.?
FDA listed 4 observations on this Form 483, mostly about production & process controls and cAPA. The opening words of each observation are shown on this page.
Who inspected CooperSurgical, Inc.?
Stephen C. Smith is named on this Form 483, for the inspection of Jul 7 – Jul 15, 2021. Each investigator has a profile showing what they cite most.
When was CooperSurgical, Inc. inspected by FDA?
The inspection ran Jul 7 – Jul 15, 2021, and the Form 483 is dated July 15, 2021.
How do I get the full Form 483 for CooperSurgical, Inc.?
Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.